Finally, Van der Zande et al. studied DLB patients with concomitant AD pathology (defined with cerebrospinal fluid tau/aβ-42 ratio) and found that these patients had lower extrastriatal FP-CIT SERT binding in limbic brain regions (i.e., left amygdala) [46]. This evidence concerns the gene MAPT and Alzheimer disease.